(Q37969708)

English

Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification

scientific article published on March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification (English)

1 reference

Europe PubMed Central

26 August 2017

0 references

0 references

phaeochromocytoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Graeme Eisenhofer

1

object named as

Graeme Eisenhofer

1 reference

Europe PubMed Central

26 August 2017

author name string

Arthur S Tischler

2

1 reference

Europe PubMed Central

26 August 2017

Ronald R de Krijger

3

1 reference

Europe PubMed Central

26 August 2017

publication date

1 March 2012

1 reference

Europe PubMed Central

26 August 2017

Endocrine Pathology

1 reference

Europe PubMed Central

26 August 2017

23

1 reference

Europe PubMed Central

26 August 2017

1

1 reference

Europe PubMed Central

26 August 2017

4-14

1 reference

Europe PubMed Central

26 August 2017

https://scigraph.springernature.com/pub.10.1007/s12022-011-9188-1

0 references

Pheochromocytoma: Rediscovery as a catecholamine-metabolizing tumor

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Measurement of urinary metadrenaline and normetadrenaline by liquid chromatography tandem mass spectrometry for the diagnosis of phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Proficiency test of plasma free and total metanephrines: report from a study group.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Pilot quality assurance programme for plasma metanephrines

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Multiparameter DNA flow-sorting demonstrates diploidy and SDHD wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Pheochromocytomas: can malignant potential be predicted?

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Predictive characteristics of malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Prognostic markers in pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Clinical experience over 48 years with pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Pheochromocytoma in Italy: a multicentric retrospective study

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

The management of benign and malignant pheochromocytoma and abdominal paraganglioma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

The Warburg effect is genetically determined in inherited pheochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Dopamine and dopa urinary excretion in patients with pheochromocytoma--diagnostic implications.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

The value of plasma markers for the clinical behaviour of phaeochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Renal tumors associated with germline SDHB mutation show distinctive morphology.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Gene expression profiling of benign and malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Stathmin as a marker for malignancy in pheochromocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Microarray analysis reveals differential expression of benign and malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Malignant pheochromocytoma: current status and initiatives for future progress

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Recommendations for biomarker identification and qualification in clinical proteomics

1 reference

https://api.crossref.org/works/10.1007%2FS12022-011-9188-1

21 January 2018

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of free plasma metanephrines enzyme immunoassay with (131)I-MIBG scan in diagnosis of pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A re-evaluation of dopamine excretion in phaeochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytoma: time to stamp out "malignancy"?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of standards in the development and implementation of clinical laboratory tests: a domestic and global perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple liquid chromatography-tandem mass spectrometry method for measuring metanephrine and normetanephrine in urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An exploration into study design for biomarker identification: issues and recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SECRETION OF CATECHOLAMINES IN MALIGNANT PHAEOCHROMOCYTOMA

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor recurrence and hypertension persistence after successful pheochromocytoma operation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for malignant pheochromocytoma: analysis of 136 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrative epigenomic and genomic analysis of malignant pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SDHA Immunohistochemistry Detects GermlineSDHAGene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal Tumors and Hereditary Pheochromocytoma-Paraganglioma Syndrome Type 4

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic Acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenal pheochromocytoma: a clinicopathologic review of 60 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current Management of Pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative measurement of plasma free metanephrines by ion-pairing solid phase extraction and liquid chromatography-tandem mass spectrometry with porous graphitic carbon column

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22180288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12022-011-9188-1

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37969708&oldid=1735143840"